tradingkey.logo

Borealis Foods Inc

BRLS

2.925USD

+0.100+3.54%
Horário de mercado ETCotações atrasadas em 15 min
62.54MValor de mercado
PerdaP/L TTM

Borealis Foods Inc

2.925

+0.100+3.54%
Mais detalhes de Borealis Foods Inc Empresa
Borealis Foods, Inc. is a food technology company that addresses global food security challenges through its research and development of nutritious and functional food products. Through its wholly owned subsidiary, Palmetto Gourmet Foods (PGF), the Company has created meals that are organic, vegan, vegetarian, Halal, Kosher, plant-based, egg free and dairy free, non-GMO, free of added monosodium glutamate (MSG) and tert-butylhydroquinone (TBHQ) free. Its initial product line is ramen noodles. Its subsidiary, PGF, uses the Company's technology to make Chef Woo ramen, a plant-based ramen meal on the market. In addition to Chef Woo, PGF also produces a range of other plant-based ramen products, including Ramen Express, its lower-cost premium ramen. Its products are available across several channels of mass merchandiser, club stores, and others. The Company's products are available at approximately 20,000 points of distribution primarily in the United States, Canada, Mexico, and Europe.
Informações da empresa
Código da empresaBRLS
Nome da EmpresaBorealis Foods Inc
Data de listagemOct 06, 2021
CEODr. Reza Soltanzadeh, M.D.
Número de funcionários147
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 06
Endereço1540 Cornwall Rd #104
CidadeOAKVILLE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalL6J 7W5
Telefone19052782200
Sitehttps://www.borealisfoods.com/
Código da empresaBRLS
Data de listagemOct 06, 2021
CEODr. Reza Soltanzadeh, M.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Reza Soltanzadeh, M.D.
Dr. Reza Soltanzadeh, M.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.66M
--
Mr. Barthelemy Helg
Mr. Barthelemy Helg
Non-Executive Chairman of the Board, Co-Founder
Non-Executive Chairman of the Board, Co-Founder
3.23M
+0.62%
Mr. Matt Talle
Mr. Matt Talle
Chief Strategy Officer
Chief Strategy Officer
214.66K
--
Ms. Pouneh Rahimi
Ms. Pouneh Rahimi
Chief Legal Officer
Chief Legal Officer
192.37K
--
Mr. Shiv Vikram Khemka
Mr. Shiv Vikram Khemka
Independent Director
Independent Director
70.00K
+40.00%
Mr. Stephen Wegrzyn
Mr. Stephen Wegrzyn
Chief Financial Officer
Chief Financial Officer
33.05K
--
Mr. Henry Wong
Mr. Henry Wong
Chief Marketing Officer
Chief Marketing Officer
14.33K
--
Mr. Steven Oyer
Mr. Steven Oyer
Independent Director
Independent Director
--
--
Mr. Shukhrat Ibragimov
Mr. Shukhrat Ibragimov
Director
Director
--
--
Ms. Ertharin Cousin
Ms. Ertharin Cousin
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Reza Soltanzadeh, M.D.
Dr. Reza Soltanzadeh, M.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.66M
--
Mr. Barthelemy Helg
Mr. Barthelemy Helg
Non-Executive Chairman of the Board, Co-Founder
Non-Executive Chairman of the Board, Co-Founder
3.23M
+0.62%
Mr. Matt Talle
Mr. Matt Talle
Chief Strategy Officer
Chief Strategy Officer
214.66K
--
Ms. Pouneh Rahimi
Ms. Pouneh Rahimi
Chief Legal Officer
Chief Legal Officer
192.37K
--
Mr. Shiv Vikram Khemka
Mr. Shiv Vikram Khemka
Independent Director
Independent Director
70.00K
+40.00%
Mr. Stephen Wegrzyn
Mr. Stephen Wegrzyn
Chief Financial Officer
Chief Financial Officer
33.05K
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 30 de mai
Atualizado em: sex, 30 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Oxus Capital Pte Ltd
24.80%
Soltanzadeh (Reza)
17.12%
Helg (Barthelemy)
15.09%
Belphar Ltd
13.32%
GSS Overseas Ltd
1.76%
Other
27.91%
Investidores
Investidores
Proporção
Oxus Capital Pte Ltd
24.80%
Soltanzadeh (Reza)
17.12%
Helg (Barthelemy)
15.09%
Belphar Ltd
13.32%
GSS Overseas Ltd
1.76%
Other
27.91%
Tipos de investidores
Investidores
Proporção
Corporation
39.88%
Individual Investor
36.07%
Investment Advisor/Hedge Fund
0.16%
Investment Advisor
0.02%
Other
23.87%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
42
16.28M
76.13%
-2.00M
2025Q1
42
16.19M
75.72%
+1.45M
2024Q4
78
16.19M
75.71%
-9.56M
2024Q3
82
16.19M
75.72%
-9.68M
2024Q2
87
16.19M
75.71%
-10.67M
2024Q1
91
16.29M
78.38%
-11.59M
2023Q4
85
3.83M
100.30%
-13.73M
2023Q3
83
3.74M
97.59%
-14.42M
2023Q2
82
3.61M
94.30%
-15.02M
2023Q1
81
3.90M
167.44%
-14.65M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Oxus Capital Pte Ltd
5.30M
24.8%
--
--
Apr 15, 2025
Soltanzadeh (Reza)
3.66M
17.12%
--
--
Apr 15, 2025
Helg (Barthelemy)
3.23M
15.09%
+20.00K
+0.62%
May 27, 2025
Belphar Ltd
2.85M
13.32%
--
--
Apr 15, 2025
GSS Overseas Ltd
375.93K
1.76%
--
--
Apr 15, 2025
Mynzhanov (Kanat)
260.00K
1.22%
+10.00K
+4.00%
May 27, 2025
Talle (Matt)
214.66K
1%
--
--
Apr 15, 2025
Rahimi (Pouneh)
192.37K
0.9%
--
--
Apr 15, 2025
Khemka (Shiv Vikram)
70.00K
0.33%
+20.00K
+40.00%
May 27, 2025
Wegrzyn (Stephen)
33.05K
0.15%
--
--
Apr 15, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI